Dawn of a New Era for ESG Investing “Look at the world around you. It may seem like an immovable, implacable place. It is not. With the slightest push—in just the right place—it can be tipped.” ― Malcolm Gladwell, The Tipping Point: How Little Things Can Make a Big Difference Passionate advocates [...] READ MORE » |
|
|
Julex Capital Macro Chart Book – August 2020 The V-Shaped recovery in equities was realized after the S&P 500 crossed pre-pandemic highs. The Fed has pushed back against inflationary concerns as they anticipate zero interest rates and continued expansion in their $7 trillion balance sheet for the foreseeable future. The federal deficit is back in the spotlights after it is... READ MORE » |
|
|
Surprising ETF Held up Well Amid FAANG Malaise The Invesco S&P 500 High Beta Portfolio (NYSEArca: SPHB) may not be the first ETF think of when high-flying growth stocks, such as the FAANG names, retreat, but SPHB held up pretty well during the recent pullback. SPHB tracks the S&P 500 High Beta Index, which “consists of the 100 stocks from the S&P 500 [...] READ MORE » |
|
|
Hedge Funds Are Doubling Down on US Corporate Bonds The federal government backstopping U.S. corporate debt during the height of the pandemic gave the bond markets a nice boost, and some hedge funds are expecting that the party isn’t over just yet. Some funds are doubling down on corporate bonds, particularly of the riskier, longer duration variety. “Lower-rated, long-duration U.S.... READ MORE » |
|
|
CRISPR Benefits Available in This Genomics ETF The fight against the novel coronavirus is putting plenty of healthcare ETFs in the spotlight this year, including the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG), but there’s much more to the ARKG story. In fact, ARKG was one of the best-performing healthcare ETFs prior to COVID-19 becoming part of the daily lexicon.... READ MORE » |
|
|
China ETFs Could Continue to Thrive Through the Rest of the Year While many global economies would like to forget Q2, for China, the second quarter kickstarted the country’s recovery from the Covid-19 pandemic. The country’s rebound in Q2 could likely continue throughout the rest of 2020. “China’s transition from a stay-at-home economy to one that is experiencing a restrained reopening has been... READ MORE » |
|
|
